Stockscreener 앱 받기
2.59
1.57%
0.04
전일 마감가:
$2.55
열려 있는:
$2.83
하루 거래량:
27,759
Relative Volume:
0.58
시가총액:
$8.14M
수익:
-
순이익/손실:
$-7.29M
주가수익비율:
-0.1063
EPS:
-24.3686
순현금흐름:
$-6.81M
1주 성능:
-11.00%
1개월 성능:
-15.64%
6개월 성능:
-27.52%
1년 성능:
-31.27%
1일 변동 폭
$2.56
$2.83
1주일 범위
$2.55
$3.00
52주 변동 폭
$2.01
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
명칭
Heartsciences Inc
전화
682-237-7781
주소
550 RESERVE ST, SUITE 360, SOUTHLAKE
HSCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
2.59 | 8.01M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
127.73 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.17 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.45 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.92 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.33 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Heartsciences Inc 주식(HSCS)의 최신 뉴스
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - The Manila Times
HeartSciences (Nasdaq: HSCS) separates device, AI-ECG FDA paths - Stock Titan
HeartSciences Inc. Announces Commercial Release of MyoVista Insights™ Version 1.1 Enhancing ECG System Capabilities - Quiver Quantitative
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with ... - Enidnews.com
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - The Manila Times
HeartSciences (Nasdaq: HSCS) rolls out MyoVista Insights 1.1 to enhance ECG workflows - Stock Titan
HeartSciences (HSCS) to Release Quarterly Earnings on Monday - Defense World
Reviewing Hims & Hers Health (NYSE:HIMS) and HeartSciences (NASDAQ:HSCS) - Defense World
S&P 500, NASDAQ and Dow continue upward trend as Wall Street rises to the edge of its all-time high; Treas - The Economic Times
Risk Off: Why MLPR stock is seen as undervaluedPrice Action & Expert-Curated Trade Recommendations - BỘ NỘI VỤ
How HeartSciences Inc. Equity Warrant stock performs in rate cut cyclesJuly 2025 Levels & Weekly Return Optimization Alerts - Newser
HeartSciences (HSCSW) Stock Analysis Report | Financials & Insights - Benzinga
Will HeartSciences Inc. Equity Warrant stock keep outperforming rivalsJuly 2025 Momentum & Reliable Intraday Trade Alerts - Newser
How HeartSciences Inc. stock performs after earningsJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
HeartSciences (HSCS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CapEx per share of HeartSciences Inc. Warrant 2022- on Heart Test Lab Rg – NASDAQ:HSCSW - TradingView
Will HeartSciences Inc. Equity Warrant stock deliver shareholder value2025 Price Momentum & Technical Pattern Recognition Alerts - moha.gov.vn
HeartSciences (NASDAQ:HSCS) and Tempus AI (NASDAQ:TEM) Financial Survey - Defense World
HeartSciences (HSCS) Stock Price, Quote, News & History - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Why HeartSciences Inc. stock is a must watch in 2025Quarterly Market Review & Daily Price Action Insights - newser.com
Why HeartSciences Inc. stock is favored by pension fundsTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com
How HeartSciences Inc. stock performs in high volatility marketsJuly 2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Can trapped investors hope for a rebound in HeartSciences Inc.2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Will HeartSciences Inc. Equity Warrant stock outperform value stocksMarket Weekly Review & Weekly High Return Forecasts - newser.com
How moving averages guide HeartSciences Inc. Equity Warrant tradingOil Prices & Precise Buy Zone Identification - newser.com
Statistical indicators supporting HeartSciences Inc.’s strengthQuarterly Portfolio Report & Long-Term Investment Growth Plans - newser.com
Sentiment analysis tools applied to HeartSciences Inc.Analyst Downgrade & Risk Managed Trade Strategies - newser.com
Technical analysis overview for HeartSciences Inc. stockJuly 2025 Decliners & Verified Short-Term Plans - newser.com
News impact scoring models applied to HeartSciences Inc.Trade Ideas & Verified Stock Trade Ideas - newser.com
Will HeartSciences Inc. stock keep outperforming rivalsWeekly Trade Report & AI Forecasted Entry and Exit Points - newser.com
What momentum shifts mean for HeartSciences Inc.Trade Entry Summary & Weekly Setup with ROI Potential - newser.com
Heartsciences Inc (HSCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.29%
0.50%
자본화:
|
볼륨(24시간):